Myriad Genetics Inc

2 de set. de 2026, 20:08 UTC

Myriad Genetics Inc is higher today, supported by strong gains in the Biotechnology sub-sector. The stock remains above its 20-day moving average.

1 de set. de 2026, 20:01 UTC

Piper Sandler downgraded Myriad Genetics to Underweight and cut the price target to $2, contributing to a decline in shares during the session.

31 de ago. de 2026, 20:07 UTC

Myriad Genetics shares are rising amid broader market strength following remarks from Warsh at the Jackson Hole Economic Symposium. The stock rebounded after earlier volatility.

28 de ago. de 2026, 20:08 UTC

Myriad Genetics shares are lower today amid rising U.S. Treasury yields and inflation concerns, with no specific company news identified for the price movement.

27 de ago. de 2026, 20:07 UTC

Myriad Genetics will participate in the Wells Fargo Healthcare Conference on September 10, 2026, as shares trade higher since Wednesday's close.

26 de ago. de 2026, 19:35 UTC

Myriad Genetics Inc shares are lower today, following a mid-morning decline amid broader economic data showing persistent inflationary pressures.

25 de ago. de 2026, 20:07 UTC

Myriad Genetics Inc shares are higher today, continuing a strong performance since Monday. The stock remains below its 20-day moving average.

24 de ago. de 2026, 20:02 UTC

Myriad Genetics Inc shares are lower amid broader market declines and geopolitical concerns. Earlier, the stock dropped significantly before stabilizing during trading.

21 de ago. de 2026, 19:26 UTC

Myriad Genetics Inc. shares are lower today, trading below their 20-day moving average amid a broader market rebound in safe-haven assets.

20 de ago. de 2026, 19:52 UTC

Myriad Genetics Inc shares are higher during Thursday's session, reaching a session high earlier. No specific company news was identified to explain the movement.

19 de ago. de 2026, 20:02 UTC

Myriad Genetics shares are trading higher, rebounding from pre-market losses amid strong buying interest during the session. The stock remains near its one-month low.

18 de ago. de 2026, 20:03 UTC

Myriad Genetics shares are trading lower amid an investigation and revised revenue guidance of $770-$790 million, down from $860-$880 million.

17 de ago. de 2026, 19:26 UTC

Myriad Genetics Inc. shares are higher today, reaching a peak late in the session, though they remain below their 20-day moving average.

14 de ago. de 2026, 19:46 UTC

Myriad Genetics Inc. shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, and disappointing Q2 results with revised revenue guidance.

13 de ago. de 2026, 19:41 UTC

Myriad Genetics shares are lower as the company faces an investigation and lowers its full-year revenue guidance to $770-$790 million.

12 de ago. de 2026, 19:31 UTC

Myriad Genetics Inc shares are lower as the company faces an investigation and reports declining Q2 revenue of $190.7 million, missing expectations.

11 de ago. de 2026, 20:06 UTC

Myriad Genetics Inc shares are lower amid a securities investigation and disappointing Q2 results, which included a revenue decline and lowered full-year guidance.

7 de ago. de 2026, 19:51 UTC

Myriad Genetics shares are higher today, driven by a broader advance in biotechnology stocks. The move breaks from a recent pattern of higher daily closes.

6 de ago. de 2026, 20:03 UTC

Shares of Myriad Genetics are trading higher today, despite fluctuations during the session. The overall trend remains positive since Wednesday's close.

5 de ago. de 2026, 21:21 UTC

Myriad Genetics Inc shares are higher in after-market hours, reflecting broader market gains amid positive technology stock performance and favorable economic data.

4 de ago. de 2026, 20:04 UTC

Myriad Genetics shares are higher today, supported by overall market gains and positive sentiment amid declining crude oil prices and comments on potential peace talks with Iran.

3 de ago. de 2026, 20:03 UTC

Myriad Genetics gains amid broader market strength, tightening revenue guidance to $770 million to $790 million while facing reimbursement challenges. Shares remain higher since Friday.

31 de jul. de 2026, 23:11 UTC

Myriad Genetics Inc shares are higher in after-market hours, recovering from earlier lows. The stock remains below its 20-day moving average.

30 de jul. de 2026, 22:51 UTC

Myriad Genetics shares fell in after-market trading following disappointing Q2 results, with revenue of $190.7 million missing expectations and a revised revenue outlook.

29 de jul. de 2026, 18:07 UTC

Myriad Genetics Inc. shares are lower today, continuing a four-session decline amid broader market concerns over rising crude oil prices and inflation worries.

28 de jul. de 2026, 18:06 UTC

Myriad Genetics faces negative sentiment after being labeled unprofitable. Shares are lower today, continuing a trend of declines over the past three sessions.

27 de jul. de 2026, 18:16 UTC

Myriad Genetics shares are lower amid a broader market trend and significant declines in crude oil prices, despite earlier session volatility.

24 de jul. de 2026, 19:36 UTC

Myriad Genetics shares are lower amid scrutiny over financial performance and stagnant revenue growth, reflecting ongoing challenges in the broader market.

22 de jul. de 2026, 20:06 UTC

Myriad Genetics Inc shares are lower today, continuing a decline from Tuesday's close amid mixed sentiment ahead of the Federal Reserve meeting.

20 de jul. de 2026, 18:22 UTC

Myriad Genetics Inc. shares are lower today, continuing a recent decline amid rising U.S. Treasury yields and inflation concerns tied to increasing oil prices.